伦瓦提尼
索拉非尼
肝细胞癌
医学
肝移植
内科学
肿瘤科
移植
胃肠病学
作者
Christian Tibor Josef Magyar,Sheron Perera,Luckshi Rajendran,Zhihao Li,Fahad Almugbel,Sophie Feng,Woo Jin Choi,Laia Aceituno,Arndt Vogel,Robert C. Grant,Nazia Selzner,Elmar Jaeckel,Nazanin Falla-Rad,Jennifer J. Knox,Eric X. Chen,Gonzalo Sapisochin,Grainne M. O’Kane
标识
DOI:10.1097/tp.0000000000005240
摘要
Hepatocellular carcinoma (HCC) recurs after liver transplantation (LT) in ~17% of patients. We aimed to retrospectively compare the outcomes of patients treated with different tyrosine kinase inhibitors (TKIs) for recurrent HCC post-LT.
科研通智能强力驱动
Strongly Powered by AbleSci AI